Drugs (Pharmaceuticals) – Page 54

CVS and Walgreens Near $10 Billion Deal to Settle Opioid Cases

The agreement would resolve thousands of lawsuits over the retailers’ role in the addiction crisis. But a large majority of state, local and tribal governments must sign on for it to take effect.

By Jan Hoffman

Depression (Mental) Drugs (Pharmaceuticals) Intellectual Property Inventions and Patents Mental Health and Disorders Psychedelic and Hallucinogenic Drugs Research

With Promise of Legalization, Psychedelic Companies Joust Over Future Profits

Cash rich start-ups are filing scores of patent claims on hallucinogens like magic mushrooms. Researchers and patient advocates worry high prices will make the therapies unaffordable.

By Andrew Jacobs

Drugs (Pharmaceuticals) Food and Drug Administration Pregnancy and Childbirth Premature Babies Regulation and Deregulation of Industry

FDA Panel Recommends Pulling Preterm Birth Drug From the Market

The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.

By Christina Jewett

Drugs (Pharmaceuticals) Drugstores Food and Drug Administration Generic Brands and Products Shortages Telemedicine Teva Pharmaceutical Industries Ltd

F.D.A. Confirms Widespread Shortages of Adderall

The agency cited Teva’s continuing supply problems as well as those of other drug makers struggling to fill the gap.

By Christina Jewett

mosaec